NPCE compared with AXGN: revenue, margins and what each company keeps, and the suppliers and customers both name

NPCENeuroPace Inc

Mkt capRevenueRevenue

AXGNAxogen, Inc.

Mkt capRevenueRevenue

Compare

NPCENeuroPace Inc

AXGNAxogen, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

NPCE: latest quarter is a loss; flow not drawable. AXGN: latest quarter not drawable.Method ›

Price

rebased to 0%

NPCE, solidAXGN, dashed

NPCENeuroPace Inc

12.28▼−5.61%· post 12.28

Mkt cap$422.2MRevenue$23MQ2 FY26Revenue$96MFY25

AXGNAxogen, Inc.

49.37▼−0.52%· post 49.37

ClosedOct 30 '26

Mkt cap$2.9BRevenue$76MQ3 FY26Revenue$225MFY25

Compare

ClosedOct 30 '26

NPCENeuroPace Inc

AXGNAxogen, Inc.

12.28▼−5.61%post 12.28

Price

49.37▼−0.52%post 49.37

$422.2M

Mkt cap

$2.9B

Q2 FY26$23M

Revenue

$76MQ3 FY26

FY25$96M

Revenue

$225MFY25

NPCE12.28▼−5.61%vsAXGN49.37▼−0.52%ClosedOct 30 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only NPCE 4

—DIXI Medical USAunlistedsupplier

GBCIGreatbatchsupplier

—Micro Systems Technologies Managementunlistedsupplier

—Rapport Therapeuticsunlistedcustomer

Shared 0

No shared counterparties.

Only AXGN 3

—Evergenunlistedsupplier

—University of Florida Research Foundation (UFRF)unlistedsupplier

—University of Texas at Austin (UTA)unlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR